APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceuticals Plant Protein

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pharmaceuticals Plant Protein Market Outlook and Growth Opportunities 2026

2 January 2026193 pages

Choose your research edition.

Industry ResearchPharmaceuticals Plant Protein Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceuticals Plant Protein Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Pharmaceuticals Plant Protein Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceuticals Plant Protein Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceuticals Plant Protein Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Pharmaceuticals Plant Protein market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pharmaceuticals Plant Protein is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pharmaceuticals Plant Protein is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmaceuticals Plant Protein is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pharmaceuticals Plant Protein market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pharmaceuticals Plant Protein market include ADM, Cargill, DuPont, Kerry Group, Manildra, Roquette, Tereos, Axiom Foods and Cosucra, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pharmaceuticals Plant Protein market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharmaceuticals Plant Protein and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharmaceuticals Plant Protein sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pharmaceuticals Plant Protein market size, projected growth trends, production technologies, key applications, and end-use industries.

Pharmaceuticals Plant Protein Segment by Company

ADM

Cargill

DuPont

Kerry Group

Manildra

Roquette

Tereos

Axiom Foods

Cosucra

CHS

Glanbia Nutritionals

Pharmaceuticals Plant Protein Segment by Type

Soy Protein

Wheat Protein

Pea Protein

Others

Pharmaceuticals Plant Protein Segment by Application

Dietary Supplements

Medicinal Protein

Others

Pharmaceuticals Plant Protein Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pharmaceuticals Plant Protein status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Pharmaceuticals Plant Protein market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pharmaceuticals Plant Protein significant trends, drivers, influence factors in global and regions.

6. To analyze Pharmaceuticals Plant Protein competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceuticals Plant Protein market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceuticals Plant Protein and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceuticals Plant Protein.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pharmaceuticals Plant Protein market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmaceuticals Plant Protein industry.

Chapter 3: Detailed analysis of Pharmaceuticals Plant Protein manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Pharmaceuticals Plant Protein in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Pharmaceuticals Plant Protein in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pharmaceuticals Plant Protein Industry Trends Table 2. Pharmaceuticals Plant Protein Industry Drivers Table 3. Pharmaceuticals Plant Protein Industry Opportunities and Challenges Table 4. Pharmaceuticals Plant Protein Industry Restraints Table 5. Global Pharmaceuticals Plant Protein Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pharmaceuticals Plant Protein Revenue Share by Company (2021-2026) Table 7. Global Pharmaceuticals Plant Protein Sales Volume by Company (kt) & (2021-2026) Table 8. Global Pharmaceuticals Plant Protein Sales Volume Share by Company (2021-2026) Table 9. Global Pharmaceuticals Plant Protein Average Price (USD/t) of Company (2021-2026) Table 10. Global Pharmaceuticals Plant Protein Company Ranking, (2024-2026) & (USD Million) Table 11. Global Pharmaceuticals Plant Protein Key Company Manufacturing Base & Headquarters Table 12. Global Pharmaceuticals Plant Protein Company, Product Type & Application Table 13. Global Pharmaceuticals Plant Protein Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Pharmaceuticals Plant Protein by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Soy Protein Table 18. Significant Companies of Wheat Protein Table 19. Significant Companies of Pea Protein Table 20. Significant Companies of Others Table 21. Global Pharmaceuticals Plant Protein Sales Volume by Type 2021 VS 2025 VS 2032 (kt) Table 22. Global Pharmaceuticals Plant Protein Sales Volume by Type (2021-2026) & (kt) Table 23. Global Pharmaceuticals Plant Protein Sales Volume by Type (2027-2032) & (kt) Table 24. Global Pharmaceuticals Plant Protein Sales Volume Share by Type (2021-2026) Table 25. Global Pharmaceuticals Plant Protein Sales Volume Share by Type (2027-2032) Table 26. Global Pharmaceuticals Plant Protein Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Pharmaceuticals Plant Protein Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Pharmaceuticals Plant Protein Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Pharmaceuticals Plant Protein Sales Value Share by Type (2021-2026) Table 30. Global Pharmaceuticals Plant Protein Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Dietary Supplements Table 32. Significant Companies of Medicinal Protein Table 33. Significant Companies of Others Table 34. Global Pharmaceuticals Plant Protein Sales Volume by Application 2021 VS 2025 VS 2032 (kt) Table 35. Global Pharmaceuticals Plant Protein Sales Volume by Application (2021-2026) & (kt) Table 36. Global Pharmaceuticals Plant Protein Sales Volume by Application (2027-2032) & (kt) Table 37. Global Pharmaceuticals Plant Protein Sales Volume Share by Application (2021-2026) Table 38. Global Pharmaceuticals Plant Protein Sales Volume Share by Application (2027-2032) Table 39. Global Pharmaceuticals Plant Protein Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Pharmaceuticals Plant Protein Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Pharmaceuticals Plant Protein Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Pharmaceuticals Plant Protein Sales Value Share by Application (2021-2026) Table 43. Global Pharmaceuticals Plant Protein Sales Value Share by Application (2027-2032) Table 44. Global Pharmaceuticals Plant Protein Sales by Region: 2021 VS 2025 VS 2032 (kt) Table 45. Global Pharmaceuticals Plant Protein Sales by Region (2021-2026) & (kt) Table 46. Global Pharmaceuticals Plant Protein Sales Market Share by Region (2021-2026) Table 47. Global Pharmaceuticals Plant Protein Sales by Region (2027-2032) & (kt) Table 48. Global Pharmaceuticals Plant Protein Sales Market Share by Region (2027-2032) Table 49. Global Pharmaceuticals Plant Protein Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Pharmaceuticals Plant Protein Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Pharmaceuticals Plant Protein Sales Value Share by Region (2021-2026) Table 52. Global Pharmaceuticals Plant Protein Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Pharmaceuticals Plant Protein Sales Value Share by Region (2027-2032) Table 54. Global Pharmaceuticals Plant Protein Market Average Price (USD/t) by Region (2021-2026) Table 55. Global Pharmaceuticals Plant Protein Market Average Price (USD/t) by Region (2027-2032) Table 56. Global Pharmaceuticals Plant Protein Sales by Country: 2021 VS 2025 VS 2032 (kt) Table 57. Global Pharmaceuticals Plant Protein Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Pharmaceuticals Plant Protein Sales by Country (2021-2026) & (kt) Table 59. Global Pharmaceuticals Plant Protein Sales Market Share by Country (2021-2026) Table 60. Global Pharmaceuticals Plant Protein Sales by Country (2027-2032) & (kt) Table 61. Global Pharmaceuticals Plant Protein Sales Market Share by Country (2027-2032) Table 62. Global Pharmaceuticals Plant Protein Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Pharmaceuticals Plant Protein Sales Value Market Share by Country (2021-2026) Table 64. Global Pharmaceuticals Plant Protein Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Pharmaceuticals Plant Protein Sales Value Market Share by Country (2027-2032) Table 66. ADM Company Information Table 67. ADM Business Overview Table 68. ADM Pharmaceuticals Plant Protein Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 69. ADM Pharmaceuticals Plant Protein Product Portfolio Table 70. ADM Recent Development Table 71. Cargill Company Information Table 72. Cargill Business Overview Table 73. Cargill Pharmaceuticals Plant Protein Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 74. Cargill Pharmaceuticals Plant Protein Product Portfolio Table 75. Cargill Recent Development Table 76. DuPont Company Information Table 77. DuPont Business Overview Table 78. DuPont Pharmaceuticals Plant Protein Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 79. DuPont Pharmaceuticals Plant Protein Product Portfolio Table 80. DuPont Recent Development Table 81. Kerry Group Company Information Table 82. Kerry Group Business Overview Table 83. Kerry Group Pharmaceuticals Plant Protein Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 84. Kerry Group Pharmaceuticals Plant Protein Product Portfolio Table 85. Kerry Group Recent Development Table 86. Manildra Company Information Table 87. Manildra Business Overview Table 88. Manildra Pharmaceuticals Plant Protein Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 89. Manildra Pharmaceuticals Plant Protein Product Portfolio Table 90. Manildra Recent Development Table 91. Roquette Company Information Table 92. Roquette Business Overview Table 93. Roquette Pharmaceuticals Plant Protein Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 94. Roquette Pharmaceuticals Plant Protein Product Portfolio Table 95. Roquette Recent Development Table 96. Tereos Company Information Table 97. Tereos Business Overview Table 98. Tereos Pharmaceuticals Plant Protein Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 99. Tereos Pharmaceuticals Plant Protein Product Portfolio Table 100. Tereos Recent Development Table 101. Axiom Foods Company Information Table 102. Axiom Foods Business Overview Table 103. Axiom Foods Pharmaceuticals Plant Protein Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 104. Axiom Foods Pharmaceuticals Plant Protein Product Portfolio Table 105. Axiom Foods Recent Development Table 106. Cosucra Company Information Table 107. Cosucra Business Overview Table 108. Cosucra Pharmaceuticals Plant Protein Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 109. Cosucra Pharmaceuticals Plant Protein Product Portfolio Table 110. Cosucra Recent Development Table 111. CHS Company Information Table 112. CHS Business Overview Table 113. CHS Pharmaceuticals Plant Protein Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 114. CHS Pharmaceuticals Plant Protein Product Portfolio Table 115. CHS Recent Development Table 116. Glanbia Nutritionals Company Information Table 117. Glanbia Nutritionals Business Overview Table 118. Glanbia Nutritionals Pharmaceuticals Plant Protein Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 119. Glanbia Nutritionals Pharmaceuticals Plant Protein Product Portfolio Table 120. Glanbia Nutritionals Recent Development Table 121. Key Raw Materials Table 122. Raw Materials Key Suppliers Table 123. Pharmaceuticals Plant Protein Distributors List Table 124. Pharmaceuticals Plant Protein Customers List Table 125. Research Programs/Design for This Report Table 126. Authors List of This Report Table 127. Secondary Sources Table 128. Primary Sources List of Figures Figure 1. Pharmaceuticals Plant Protein Product Image Figure 2. Global Pharmaceuticals Plant Protein Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmaceuticals Plant Protein Sales Value (2021-2032) & (US$ Million) Figure 4. Global Pharmaceuticals Plant Protein Sales (2021-2032) & (kt) Figure 5. Global Pharmaceuticals Plant Protein Sales Average Price (USD/t) & (2021-2032) Figure 6. Global Pharmaceuticals Plant Protein Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Soy Protein Image Figure 10. Wheat Protein Image Figure 11. Pea Protein Image Figure 12. Others Image Figure 13. Global Pharmaceuticals Plant Protein Sales Volume by Type (2021 VS 2025 VS 2032) & (kt) Figure 14. Global Pharmaceuticals Plant Protein Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Pharmaceuticals Plant Protein Sales Volume Share by Type (2021-2032) Figure 16. Global Pharmaceuticals Plant Protein Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Pharmaceuticals Plant Protein Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Pharmaceuticals Plant Protein Sales Value Share by Type (2021-2032) Figure 19. Dietary Supplements Image Figure 20. Medicinal Protein Image Figure 21. Others Image Figure 22. Global Pharmaceuticals Plant Protein Sales Volume by Application (2021 VS 2025 VS 2032) & (kt) Figure 23. Global Pharmaceuticals Plant Protein Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Pharmaceuticals Plant Protein Sales Volume Share by Application (2021-2032) Figure 25. Global Pharmaceuticals Plant Protein Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Pharmaceuticals Plant Protein Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Pharmaceuticals Plant Protein Sales Value Share by Application (2021-2032) Figure 28. Global Pharmaceuticals Plant Protein Sales by Region: 2021 VS 2025 VS 2032 (kt) Figure 29. Global Pharmaceuticals Plant Protein Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Pharmaceuticals Plant Protein Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Pharmaceuticals Plant Protein Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Pharmaceuticals Plant Protein Sales Value (2021-2032) & (US$ Million) Figure 33. North America Pharmaceuticals Plant Protein Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Pharmaceuticals Plant Protein Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Pharmaceuticals Plant Protein Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Pharmaceuticals Plant Protein Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Pharmaceuticals Plant Protein Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Pharmaceuticals Plant Protein Sales Value (2021-2032) & (US$ Million) Figure 39. South America Pharmaceuticals Plant Protein Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Pharmaceuticals Plant Protein Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Pharmaceuticals Plant Protein Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Pharmaceuticals Plant Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Pharmaceuticals Plant Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Pharmaceuticals Plant Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Pharmaceuticals Plant Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Pharmaceuticals Plant Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Pharmaceuticals Plant Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Pharmaceuticals Plant Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Pharmaceuticals Plant Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Pharmaceuticals Plant Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Pharmaceuticals Plant Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Pharmaceuticals Plant Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Pharmaceuticals Plant Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Pharmaceuticals Plant Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Pharmaceuticals Plant Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Pharmaceuticals Plant Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Pharmaceuticals Plant Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Pharmaceuticals Plant Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Pharmaceuticals Plant Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Pharmaceuticals Plant Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Pharmaceuticals Plant Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Pharmaceuticals Plant Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Pharmaceuticals Plant Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Pharmaceuticals Plant Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Pharmaceuticals Plant Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Pharmaceuticals Plant Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Pharmaceuticals Plant Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Pharmaceuticals Plant Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Pharmaceuticals Plant Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Pharmaceuticals Plant Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Pharmaceuticals Plant Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Pharmaceuticals Plant Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Pharmaceuticals Plant Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Pharmaceuticals Plant Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Pharmaceuticals Plant Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Pharmaceuticals Plant Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Pharmaceuticals Plant Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Pharmaceuticals Plant Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Pharmaceuticals Plant Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Pharmaceuticals Plant Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Pharmaceuticals Plant Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Pharmaceuticals Plant Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Pharmaceuticals Plant Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Pharmaceuticals Plant Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Pharmaceuticals Plant Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Pharmaceuticals Plant Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Pharmaceuticals Plant Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Pharmaceuticals Plant Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Pharmaceuticals Plant Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Pharmaceuticals Plant Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Pharmaceuticals Plant Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Pharmaceuticals Plant Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Pharmaceuticals Plant Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Pharmaceuticals Plant Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Pharmaceuticals Plant Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Pharmaceuticals Plant Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Pharmaceuticals Plant Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Pharmaceuticals Plant Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Pharmaceuticals Plant Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Pharmaceuticals Plant Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Pharmaceuticals Plant Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Pharmaceuticals Plant Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Pharmaceuticals Plant Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Pharmaceuticals Plant Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Pharmaceuticals Plant Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Pharmaceuticals Plant Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Pharmaceuticals Plant Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Pharmaceuticals Plant Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Pharmaceuticals Plant Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Pharmaceuticals Plant Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Pharmaceuticals Plant Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Pharmaceuticals Plant Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Pharmaceuticals Plant Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Pharmaceuticals Plant Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Pharmaceuticals Plant Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Pharmaceuticals Plant Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Pharmaceuticals Plant Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Pharmaceuticals Plant Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Pharmaceuticals Plant Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Pharmaceuticals Plant Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Pharmaceuticals Plant Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Pharmaceuticals Plant Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Pharmaceuticals Plant Protein Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Pharmaceuticals Plant Protein Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Pharmaceuticals Plant Protein Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Pharmaceuticals Plant Protein Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Pharmaceuticals Plant Protein Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Soy Protein
  • Wheat Protein
  • Pea Protein
  • Others
Applications
  • Dietary Supplements
  • Medicinal Protein
  • Others
Companies covered
  • ADM
  • Cargill
  • DuPont
  • Kerry Group
  • Manildra
  • Roquette
  • Tereos
  • Axiom Foods
  • Cosucra
  • CHS
  • Glanbia Nutritionals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pharmaceuticals Plant Protein Sales Value (2021-2032)
  4. 1.2.2 Global Pharmaceuticals Plant Protein Sales Volume (2021-2032)
  5. 1.2.3 Global Pharmaceuticals Plant Protein Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Pharmaceuticals Plant Protein Market Dynamics
  1. 2.1 Pharmaceuticals Plant Protein Industry Trends
  2. 2.2 Pharmaceuticals Plant Protein Industry Drivers
  3. 2.3 Pharmaceuticals Plant Protein Industry Opportunities and Challenges
  4. 2.4 Pharmaceuticals Plant Protein Industry Restraints
3 Pharmaceuticals Plant Protein Market by Company
  1. 3.1 Global Pharmaceuticals Plant Protein Company Revenue Ranking in 2025
  2. 3.2 Global Pharmaceuticals Plant Protein Revenue by Company (2021-2026)
  3. 3.3 Global Pharmaceuticals Plant Protein Sales Volume by Company (2021-2026)
  4. 3.4 Global Pharmaceuticals Plant Protein Average Price by Company (2021-2026)
  5. 3.5 Global Pharmaceuticals Plant Protein Company Ranking (2024-2026)
  6. 3.6 Global Pharmaceuticals Plant Protein Company Manufacturing Base and Headquarters
  7. 3.7 Global Pharmaceuticals Plant Protein Company Product Type and Application
  8. 3.8 Global Pharmaceuticals Plant Protein Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Pharmaceuticals Plant Protein Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Pharmaceuticals Plant Protein Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Pharmaceuticals Plant Protein Market by Type
  1. 4.1 Pharmaceuticals Plant Protein Type Introduction
  2. 4.1.1 Soy Protein
  3. 4.1.2 Wheat Protein
  4. 4.1.3 Pea Protein
  5. 4.1.4 Others
  6. 4.2 Global Pharmaceuticals Plant Protein Sales Volume by Type
  7. 4.2.1 Global Pharmaceuticals Plant Protein Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Pharmaceuticals Plant Protein Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Pharmaceuticals Plant Protein Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Pharmaceuticals Plant Protein Sales Value by Type
  11. 4.3.1 Global Pharmaceuticals Plant Protein Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Pharmaceuticals Plant Protein Sales Value by Type (2021-2032)
  13. 4.3.3 Global Pharmaceuticals Plant Protein Sales Value Share by Type (2021-2032)
5 Pharmaceuticals Plant Protein Market by Application
  1. 5.1 Pharmaceuticals Plant Protein Application Introduction
  2. 5.1.1 Dietary Supplements
  3. 5.1.2 Medicinal Protein
  4. 5.1.3 Others
  5. 5.2 Global Pharmaceuticals Plant Protein Sales Volume by Application
  6. 5.2.1 Global Pharmaceuticals Plant Protein Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pharmaceuticals Plant Protein Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Pharmaceuticals Plant Protein Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Pharmaceuticals Plant Protein Sales Value by Application
  10. 5.3.1 Global Pharmaceuticals Plant Protein Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Pharmaceuticals Plant Protein Sales Value by Application (2021-2032)
  12. 5.3.3 Global Pharmaceuticals Plant Protein Sales Value Share by Application (2021-2032)
6 Pharmaceuticals Plant Protein Regional Sales and Value Analysis
  1. 6.1 Global Pharmaceuticals Plant Protein Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pharmaceuticals Plant Protein Sales by Region (2021-2032)
  3. 6.2.1 Global Pharmaceuticals Plant Protein Sales by Region: 2021-2026
  4. 6.2.2 Global Pharmaceuticals Plant Protein Sales by Region (2027-2032)
  5. 6.3 Global Pharmaceuticals Plant Protein Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Pharmaceuticals Plant Protein Sales Value by Region (2021-2032)
  7. 6.4.1 Global Pharmaceuticals Plant Protein Sales Value by Region: 2021-2026
  8. 6.4.2 Global Pharmaceuticals Plant Protein Sales Value by Region (2027-2032)
  9. 6.5 Global Pharmaceuticals Plant Protein Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Pharmaceuticals Plant Protein Sales Value (2021-2032)
  12. 6.6.2 North America Pharmaceuticals Plant Protein Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Pharmaceuticals Plant Protein Sales Value (2021-2032)
  15. 6.7.2 Europe Pharmaceuticals Plant Protein Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Pharmaceuticals Plant Protein Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Pharmaceuticals Plant Protein Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Pharmaceuticals Plant Protein Sales Value (2021-2032)
  21. 6.9.2 South America Pharmaceuticals Plant Protein Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Pharmaceuticals Plant Protein Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Pharmaceuticals Plant Protein Sales Value Share by Country, 2025 VS 2032
7 Pharmaceuticals Plant Protein Country-level Sales and Value Analysis
  1. 7.1 Global Pharmaceuticals Plant Protein Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pharmaceuticals Plant Protein Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Pharmaceuticals Plant Protein Sales by Country (2021-2032)
  4. 7.3.1 Global Pharmaceuticals Plant Protein Sales by Country (2021-2026)
  5. 7.3.2 Global Pharmaceuticals Plant Protein Sales by Country (2027-2032)
  6. 7.4 Global Pharmaceuticals Plant Protein Sales Value by Country (2021-2032)
  7. 7.4.1 Global Pharmaceuticals Plant Protein Sales Value by Country (2021-2026)
  8. 7.4.2 Global Pharmaceuticals Plant Protein Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Pharmaceuticals Plant Protein Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Pharmaceuticals Plant Protein Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Pharmaceuticals Plant Protein Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Pharmaceuticals Plant Protein Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Pharmaceuticals Plant Protein Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Pharmaceuticals Plant Protein Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Pharmaceuticals Plant Protein Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Pharmaceuticals Plant Protein Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Pharmaceuticals Plant Protein Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Pharmaceuticals Plant Protein Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Pharmaceuticals Plant Protein Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Pharmaceuticals Plant Protein Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Pharmaceuticals Plant Protein Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Pharmaceuticals Plant Protein Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Pharmaceuticals Plant Protein Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Pharmaceuticals Plant Protein Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Pharmaceuticals Plant Protein Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Pharmaceuticals Plant Protein Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Pharmaceuticals Plant Protein Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Pharmaceuticals Plant Protein Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Pharmaceuticals Plant Protein Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Pharmaceuticals Plant Protein Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Pharmaceuticals Plant Protein Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Pharmaceuticals Plant Protein Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Pharmaceuticals Plant Protein Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Pharmaceuticals Plant Protein Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Pharmaceuticals Plant Protein Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Pharmaceuticals Plant Protein Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Pharmaceuticals Plant Protein Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Pharmaceuticals Plant Protein Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Pharmaceuticals Plant Protein Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Pharmaceuticals Plant Protein Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Pharmaceuticals Plant Protein Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Pharmaceuticals Plant Protein Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Pharmaceuticals Plant Protein Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Pharmaceuticals Plant Protein Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Pharmaceuticals Plant Protein Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Pharmaceuticals Plant Protein Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Pharmaceuticals Plant Protein Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Pharmaceuticals Plant Protein Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Pharmaceuticals Plant Protein Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Pharmaceuticals Plant Protein Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Pharmaceuticals Plant Protein Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Pharmaceuticals Plant Protein Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Pharmaceuticals Plant Protein Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Pharmaceuticals Plant Protein Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Pharmaceuticals Plant Protein Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Pharmaceuticals Plant Protein Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Pharmaceuticals Plant Protein Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Pharmaceuticals Plant Protein Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Pharmaceuticals Plant Protein Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Pharmaceuticals Plant Protein Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Pharmaceuticals Plant Protein Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Pharmaceuticals Plant Protein Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Pharmaceuticals Plant Protein Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Pharmaceuticals Plant Protein Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Pharmaceuticals Plant Protein Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Pharmaceuticals Plant Protein Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Pharmaceuticals Plant Protein Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Pharmaceuticals Plant Protein Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Pharmaceuticals Plant Protein Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Pharmaceuticals Plant Protein Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Pharmaceuticals Plant Protein Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Pharmaceuticals Plant Protein Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Pharmaceuticals Plant Protein Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Pharmaceuticals Plant Protein Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Pharmaceuticals Plant Protein Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Pharmaceuticals Plant Protein Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Pharmaceuticals Plant Protein Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Pharmaceuticals Plant Protein Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Pharmaceuticals Plant Protein Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Pharmaceuticals Plant Protein Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Pharmaceuticals Plant Protein Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Pharmaceuticals Plant Protein Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Pharmaceuticals Plant Protein Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Pharmaceuticals Plant Protein Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Pharmaceuticals Plant Protein Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Pharmaceuticals Plant Protein Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Pharmaceuticals Plant Protein Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Pharmaceuticals Plant Protein Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Pharmaceuticals Plant Protein Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Pharmaceuticals Plant Protein Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Pharmaceuticals Plant Protein Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Pharmaceuticals Plant Protein Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 ADM
  2. 8.1.1 ADM Company Information
  3. 8.1.2 ADM Business Overview
  4. 8.1.3 ADM Pharmaceuticals Plant Protein Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 ADM Pharmaceuticals Plant Protein Product Portfolio
  6. 8.1.5 ADM Recent Developments
  7. 8.2 Cargill
  8. 8.2.1 Cargill Company Information
  9. 8.2.2 Cargill Business Overview
  10. 8.2.3 Cargill Pharmaceuticals Plant Protein Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Cargill Pharmaceuticals Plant Protein Product Portfolio
  12. 8.2.5 Cargill Recent Developments
  13. 8.3 DuPont
  14. 8.3.1 DuPont Company Information
  15. 8.3.2 DuPont Business Overview
  16. 8.3.3 DuPont Pharmaceuticals Plant Protein Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 DuPont Pharmaceuticals Plant Protein Product Portfolio
  18. 8.3.5 DuPont Recent Developments
  19. 8.4 Kerry Group
  20. 8.4.1 Kerry Group Company Information
  21. 8.4.2 Kerry Group Business Overview
  22. 8.4.3 Kerry Group Pharmaceuticals Plant Protein Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Kerry Group Pharmaceuticals Plant Protein Product Portfolio
  24. 8.4.5 Kerry Group Recent Developments
  25. 8.5 Manildra
  26. 8.5.1 Manildra Company Information
  27. 8.5.2 Manildra Business Overview
  28. 8.5.3 Manildra Pharmaceuticals Plant Protein Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Manildra Pharmaceuticals Plant Protein Product Portfolio
  30. 8.5.5 Manildra Recent Developments
  31. 8.6 Roquette
  32. 8.6.1 Roquette Company Information
  33. 8.6.2 Roquette Business Overview
  34. 8.6.3 Roquette Pharmaceuticals Plant Protein Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Roquette Pharmaceuticals Plant Protein Product Portfolio
  36. 8.6.5 Roquette Recent Developments
  37. 8.7 Tereos
  38. 8.7.1 Tereos Company Information
  39. 8.7.2 Tereos Business Overview
  40. 8.7.3 Tereos Pharmaceuticals Plant Protein Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Tereos Pharmaceuticals Plant Protein Product Portfolio
  42. 8.7.5 Tereos Recent Developments
  43. 8.8 Axiom Foods
  44. 8.8.1 Axiom Foods Company Information
  45. 8.8.2 Axiom Foods Business Overview
  46. 8.8.3 Axiom Foods Pharmaceuticals Plant Protein Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Axiom Foods Pharmaceuticals Plant Protein Product Portfolio
  48. 8.8.5 Axiom Foods Recent Developments
  49. 8.9 Cosucra
  50. 8.9.1 Cosucra Company Information
  51. 8.9.2 Cosucra Business Overview
  52. 8.9.3 Cosucra Pharmaceuticals Plant Protein Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Cosucra Pharmaceuticals Plant Protein Product Portfolio
  54. 8.9.5 Cosucra Recent Developments
  55. 8.10 CHS
  56. 8.10.1 CHS Company Information
  57. 8.10.2 CHS Business Overview
  58. 8.10.3 CHS Pharmaceuticals Plant Protein Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 CHS Pharmaceuticals Plant Protein Product Portfolio
  60. 8.10.5 CHS Recent Developments
  61. 8.11 Glanbia Nutritionals
  62. 8.11.1 Glanbia Nutritionals Company Information
  63. 8.11.2 Glanbia Nutritionals Business Overview
  64. 8.11.3 Glanbia Nutritionals Pharmaceuticals Plant Protein Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Glanbia Nutritionals Pharmaceuticals Plant Protein Product Portfolio
  66. 8.11.5 Glanbia Nutritionals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pharmaceuticals Plant Protein Value Chain Analysis
  2. 9.1.1 Pharmaceuticals Plant Protein Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pharmaceuticals Plant Protein Sales Mode & Process
  6. 9.2 Pharmaceuticals Plant Protein Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pharmaceuticals Plant Protein Distributors
  9. 9.2.3 Pharmaceuticals Plant Protein Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst